Results 21 to 30 of about 344,012 (256)

The model for end-stage liver disease (MELD) [PDF]

Hepatology, 2007
Abstract The Model for End-stage Liver Disease (MELD) was initially created to predict survival in patients with complications of portal hypertension undergoing elective placement of transjugular intrahepatic portosystemic shunts.
Patrick S, Kamath, W Ray, Kim
openaire   +2 more sources

Evaluation of the correlation between six scoring systems for assessing the severity of end-stage liver disease and intraoperative blood loss during liver transplantation: a retrospective study

Clinical Transplantation and Research
Background : Patients with end-stage liver disease (ESLD) are particularly susceptible to intraoperative hemorrhage during liver transplantation (LT), a risk partly attributable to coagulopathy.
Amer Majeed, Noon E Abdelgadir, Momina Amer, Muhammad Shabbir, Mohammed Ibrahim, Mohamad S Nagy, Bilal Tufail, Luluah Altukhaifi, Areej A G AlFattani   +8 more
doaj   +1 more source

Clinical presentation of autoimmune hepatitis in Pakistani children

The Pan African Medical Journal, 2018
INTRODUCTION: Autoimmune hepatitis (AIH) is one of the most common disorder resulting in end stage liver disease (ESLD) among children. Scarce data is available in this regard from Pakistan.
Ghous Bux Somroo, Ayesha Aslam Rai, Nasir Hassan Luck, Zaigham Abbas   +3 more
doaj   +1 more source

Sarcopenia in Children With End‐Stage Liver Disease

Journal of Pediatric Gastroenterology and Nutrition, 2018
ABSTRACTBackground:Sarcopenia, reflected by decreased psoas muscle surface area (PMSA), has been identified as a novel and independent predictor of wait‐list mortality and outcomes in adult liver transplantation (LT). We hypothesized that children with end‐stage liver disease (ESLD) would have smaller PMSA than healthy controls.Methods:Computer ...
Eberhard, Lurz, Hiten, Patel, Richard G, Frimpong, Amanda, Ricciuto, Mohit, Kehar, Paul W, Wales, Alexander J, Towbin, Govind B, Chavhan, Binita M, Kamath, Vicky L, Ng   +9 more
openaire   +3 more sources

The Yin and the Yang of Hemostasis in End-Stage-Liver-Disease

Journal of Clinical Medicine, 2023
Patients with end stage liver disease (ESLD) undergoing liver transplantation are prone to thromboses both while on the waiting list or in the perioperative period. This hypercoagulability is associated with significant endothelial dysfunction (ED) due to nitric oxide dysregulation.
Fuat H. Saner, Ecaterina Scarlatescu, Dieter Clemens Broering, Dmitri Bezinover   +3 more
openaire   +2 more sources

Cell therapy in end-stage liver disease: replace and remodel

Stem Cell Research & Therapy, 2023
Liver disease is prevalent worldwide. When it reaches the end stage, mortality rises to 50% or more. Although liver transplantation has emerged as the most efficient treatment for end-stage liver disease, its application has been limited by the scarcity ...
Xin-Hao Hu, Lan Chen, Hao Wu, Yang-Bo Tang, Qiu-Min Zheng, Xu-Yong Wei, Qiang Wei, Qi Huang, Jian Chen, Xiao Xu   +9 more
doaj   +1 more source

Albumin for End-Stage Liver Disease

The Korean Journal of Internal Medicine, 2012
Albumin has been widely used in patients with cirrhosis in an attempt to improve circulatory and renal functions. The benefits of albumin infusions in preventing the deterioration in renal function associated with large-volume paracentesis, spontaneous bacterial peritonitis, and established hepatorenal syndrome in conjunction with a vasoconstrictor are
openaire   +2 more sources

European Standard Clinical Practice Guideline and EXPeRT Recommendations for the Diagnosis and Management of Gastroenteropancreatic Neuroendocrine Neoplasms in Children and Adolescents

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) are extremely rare and clinically heterogeneous. Management has largely been extrapolated from adult practice. This European Standard Clinical Practice Guideline (ESCP), developed by the EXPeRT network in collaboration with adult NEN experts, provides (adult) evidence ...
Michaela Kuhlen, Calogero Virgone, Antje Redlich, Michael Abele, Ricardo Lopez‐Almaraz, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Maja Mazic Cesen, Andrea Ferrari, Malgorzata A. Krawczyk, Yves Reguerre, Dominik T. Schneider, Ines B. Brecht, Charlotte Rigaud, Bilgehan Yalcin, Rainer Claus, Christian Vokuhl, Constantin Lapa, Jörg Fuchs, Segolene Hescot, Thomas Walter, Julien Hadoux, Daniel Orbach   +23 more
wiley   +1 more source

Serial assessment of hepatic encephalopathy in patients hospitalised for acute decompensation of cirrhosis

Annals of Hepatology, 2019
Introduction and aim: Hepatic encephalopathy (HE) is a frequent complication of cirrhosis, but the clinical and prognostic significance of the progression of mental status in hospitalised cirrhotics is unknown.
Dariana C. Maggi, Ariane Borgonovo, Emília T. Bansho, Pedro E. Soares-Silva, Telma E. Silva, Bruno S. Colombo, Letícia M. Wildner, Maria L. Bazzo, Esther B. Dantas-Correa, Janaína L. Narciso-Schiavon, Leonardo L. Schiavon   +10 more
doaj   +1 more source

Role of Rifaximin in Prevention of Recurrent Hepatic Encephalopathy in Chronic Liver Disease

Journal of Bahria University Medical and Dental College, 2020
Objectives: To determine the efficacy (in terms of recurrence) of rifaximin in Hepatic Encephalopathy (HE) in chronic liver disease. Study Design and Setting: A descriptive study carried out from 4th September 2018 to 3rd March 2019 at the department of
Sahar Farzand, Abdul Latif Khattak, Rafi ud Din, Karamat Hussain Shah Bukhari, Muhammad Shahbaz Amin, Shahzeb Ahmed Satti   +5 more
doaj   +1 more source